spec sheet10 rows
4-AcO-DMT (4-acetoxy-N,N-dimethyltryptamine, psilacetin, O-acetylpsilocin) is a semisynthetic tryptamine and the acetate ester of psilocin, the active metabolite of psilocybin. It functions largely as a prodrug: ester hydrolysis yields psilocin, a high-efficacy agonist at the 5-HT2A serotonin receptor that mediates its psilocybin-like psychedelic effects. In vitro studies with human liver microsomes confirm that hydrolysis to psilocin is the dominant biotransformation, followed by glucuronidation and oxidation. Structure-activity work shows that acetylation reduces 5-HT2A potency in cell assays yet has little effect on the mouse head-twitch response, consistent with in vivo deacetylation, and the compound fully substitutes for DOM in drug-discrimination assays. It has become one of the more widely encountered designer tryptamines, valued for its comparative chemical stability relative to mushroom material.
- Prodrug of psilocin; mushroom-like effects
- More measurable than dried mushrooms
- Low physiological toxicity
- Hydrolyzed in vivo to psilocin, a 5-HT2A agonist
- Early nausea
- Anxiety or overwhelm at higher exposure
Mechanism
4-AcO-DMT carries an acetoxy group that the body is believed to remove (deacetylation), releasing psilocin; psilocin then agonizes the receptor to produce the classic psychedelic state, with additional and 5-HT2C activity. Because the active species is psilocin, users generally report a mushroom-like character rather than an LSD-like one.
receptor fingerprint
receptoragonist (via psilocin)
/ 5-HT2C receptorsagonist
Safetyrisks and cautions, not medical advice
Physiological toxicity appears low, in line with psilocin, but the experience is psychologically potent and dose-sensitive; nausea is common early on. Avoid with MAOIs and strong serotonergics (serotonin toxicity) and with a psychosis or bipolar history. It is a newer research chemical, so long-term human data are limited and correct identity/purity matter. Not medical advice.
Subjective profileweighing the evidence above
Of the designer tryptamines this is one of the more defensible; it hydrolyses to psilocin, so the experience matches mushrooms with a dose you can actually measure, and physiological toxicity looks low. It is still a newer research chemical, so identity and purity matter, and MAOIs or a psychosis history rule it out.
Resources
No suppliers are provided for compounds like this. This entry is here for reference.
Research
- 2016first citedCorrelates of new psychoactive substance use among a self-selected sample of nightclub attendee…
- 2026most recent5-HT2A receptors in the prelimbic cortex VIP-expressing interneurons: A mechanism for psychedel…
- 1.Investigation of the Structure-Activity Relationships of Psilocybin Analogues
- 2.5-HT2A receptors in the prelimbic cortex VIP-expressing interneurons: A mechanism for psychedelic-induced innate fear attenuation
- 3.Discriminative Stimulus Effects of Substituted Tryptamines in Rats.
- 4.Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS.
- 5.Development and validation of an analytical method for the determination of select 4-position ring-substituted tryptamines in plasma by liquid chromatography-tandem mass spectrometry.
- 6.Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.
6 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
Is it like mushrooms?
Yes; the body converts it to psilocin, the active compound in psilocybin mushrooms, so the character is described as mushroom-like.
Why choose it over mushrooms?
It is more consistent and easier to measure than variable dried mushrooms.
What to avoid it with?
MAOIs and strong serotonergics (serotonin toxicity); not for people with a psychosis or bipolar history.
Limitations of the evidence
- Limited long-term data (newer RC)
Adverse effects
- Early nausea
- Anxiety or overwhelm at higher exposure